Does ALECTINIB Cause Neoplasm recurrence? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm recurrence have been filed in association with ALECTINIB (ALECENSA). This represents 0.1% of all adverse event reports for ALECTINIB.
9
Reports of Neoplasm recurrence with ALECTINIB
0.1%
of all ALECTINIB reports
3
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm recurrence From ALECTINIB?
Of the 9 reports, 3 (33.3%) resulted in death, and 1 (11.1%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALECTINIB. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does ALECTINIB Cause?
Death (702)
Fatigue (618)
Constipation (525)
Off label use (495)
No adverse event (488)
Disease progression (366)
Rash (312)
Dyspnoea (296)
Drug ineffective (269)
Myalgia (268)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which ALECTINIB Alternatives Have Lower Neoplasm recurrence Risk?
ALECTINIB vs ALEMTUZUMAB
ALECTINIB vs ALENDRONATE
ALECTINIB vs ALENDRONATE\CHOLECALCIFEROL
ALECTINIB vs ALENDRONIC ACID
ALECTINIB vs ALEVE